A. Pons-Grífols

Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice

B. Clotet, J. Segalés, T. Pumarola, 2022, Frontiers in Microbiology.

A Novel Monoclonal Antibody Targeting a Large Surface of the Receptor Binding Motif Shows Pan-neutralizing SARS-CoV-2 Activity Including BQ.1.1 Variant

J. Segalés, S. Marfil, J. Blanco, 2023, bioRxiv.

SARS-CoV-2 B.1.351 (beta) variant shows enhanced infectivity in K18-hACE2 transgenic mice and expanded tropism to wildtype mice compared to B.1 variant

B. Clotet, J. Segalés, V. Guallar, 2021, bioRxiv.

An engineered HIV-1 Gag-based VLP displaying high antigen density induces strong antibody-dependent functional immune responses

B. Clotet, S. Marfil, J. Blanco, 2023, npj Vaccines.

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization

B. Clotet, S. Marfil, M. Massanella, 2023, iScience.

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform—Analysis of Production and Immunogenicity

B. Clotet, J. Blanco, J. Carrillo, 2023, International journal of molecular sciences.

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant

B. Clotet, J. Segalés, S. Marfil, 2023, bioRxiv.